WHO approves first malaria treatment specifically for infants
The World Health Organization (WHO) has announced the prequalification of a malaria treatment designed specifically for newborns and infants, marking a major milestone in the fight against the disease. The newly approved drug, Artemether-lumefantrine, is the first antimalarial formulation tailored for the youngest and most vulnerable patients affected by the mosquito-borne illness. According to the…


